Pre-ANDA litigation: strategies and tactics for developing a drug product and patent portfolio
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Chicago
American Bar Association
[2018]
|
| Ausgabe: | Second edition |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | Literaturangaben und Index |
| Beschreibung: | xxvii, 1007 Seiten |
| ISBN: | 9781641051187 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV045265390 | ||
| 003 | DE-604 | ||
| 005 | 20190114 | ||
| 007 | t | ||
| 008 | 181030s2018 xxu |||| 00||| eng d | ||
| 010 | |a 018016836 | ||
| 020 | |a 9781641051187 |9 978-1-64105-118-7 | ||
| 035 | |a (DE-599)BVBBV045265390 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c US | ||
| 049 | |a DE-M382 | ||
| 050 | 0 | |a KF3133.D78 | |
| 082 | 0 | |a 346.7304/86 |2 23 | |
| 245 | 1 | 0 | |a Pre-ANDA litigation |b strategies and tactics for developing a drug product and patent portfolio |c Kenneth L. Dorsney, editor-in-chief |
| 250 | |a Second edition | ||
| 264 | 1 | |a Chicago |b American Bar Association |c [2018] | |
| 300 | |a xxvii, 1007 Seiten | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Literaturangaben und Index | ||
| 650 | 4 | |a Drugs |z United States |x Patents | |
| 650 | 4 | |a Patent laws and legislation |z United States | |
| 650 | 4 | |a Drug approval |z United States | |
| 650 | 4 | |a Pharmacy |x Law and legislation |z United States | |
| 650 | 4 | |a Biotechnology |z United States |x Patents | |
| 700 | 1 | |a Dorsney, Kenneth L. |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe, EPUB |z 978-1-64105-119-4 |
| 856 | 4 | 2 | |m LoC Fremddatenuebernahme |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030653247&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-030653247 | ||
Datensatz im Suchindex
| _version_ | 1804179024688185344 |
|---|---|
| adam_text | PRE-ANDA LITIGATION
/
: 2018
TABLE OF CONTENTS / INHALTSVERZEICHNIS
COORDINATING NEW DRUG APPLICATION (NDA) AND PATENT PORTFOLIO STRATEGY
PRECLINICAL R&D
PRECLINICAL PATENT CONSIDERATIONS
CLINICAL TRIALS AND REGULATORY CONSIDERATIONS
CLINICAL TRIAL/PATENT CONSIDERATIONS
TRADEMARK (TM) AND NONPROPRIETARY NAME CONSIDERATIONS
INVESTIGATIONAL NEW DRUG (IND) AND NEW DRUG APPLICATIONS (NDA)
REGULATORY EXCLUSIVITY
OVERVIEW OF THE NDA REVIEW PROCESS
ORANGE BOOK LISTABLE PATENTS
POSTMARKETING REGULATORY REQUIREMENTS AND LIFE CYCLE MANAGEMENT
CONTINUED PATENT PORTFOLIO DEVELOPMENT BEFORE THE PATENT OFFICE
ACQUIRING AND IN-LICENSING PHARMACEUTICAL PRODUCTS : DUE DILIGENCE
ISSUES
PRE-LITIGATION INVESTIGATIONS AND DUE DILIGENCE
MARKET ENTRY BUSINESS CONSIDERATIONS FOR GENERIC COMPANIES
SELECTION OF GENERIC DRUG CANDIDATES
INTELLECTUAL PROPERTY CONSIDERATIONS RELATED TO GENERIC PRODUCTS
PREPARATION OF NONINFRINGEMENT/INVALIDITY LEGAL OPINIONS
PREPARING YOUR ANDA WITH AN EYE TOWARD APPROVAL AND LITIGATION
SECTION VIII CARVE-OUTS
OBTAINING ANDA APPROVAL AND RIGHT TO MARKET
PROVIDING NOTICE TO THE NDA HOLDER
EVALUATING SCENARIOS FOR LAUNCH, INCLUDING MARKETING AND MANUFACTURING
DEVELOPMENTS
INTERPLAY BETWEEN INTER PARTES REVIEW (IPR) AND ANDA LITIGATION
CITIZEN PETITIONS
EXPEDITED REGULATORY PATHWAYS
REMS 101 FOR ANDA LITIGATORS AND COUNSELORS
REGULATORY COMPLIANCE : INSPECTIONS AND THEIR CONSEQUENCES
BIOLOGIC DRUGS AND THE BIOLOGICS PRICE COMPETITION AND INNOVATION ACT
PHARMACEUTICAL REGULATION AND APPROVAL IN FOREIGN COUNTRIES
DIESES SCHRIFTSTUECK WURDE MASCHINELL ERZEUGT.
|
| any_adam_object | 1 |
| author2 | Dorsney, Kenneth L. |
| author2_role | edt |
| author2_variant | k l d kl kld |
| author_facet | Dorsney, Kenneth L. |
| building | Verbundindex |
| bvnumber | BV045265390 |
| callnumber-first | K - Law |
| callnumber-label | KF3133 |
| callnumber-raw | KF3133.D78 |
| callnumber-search | KF3133.D78 |
| callnumber-sort | KF 43133 D78 |
| callnumber-subject | KF - United States |
| ctrlnum | (DE-599)BVBBV045265390 |
| dewey-full | 346.7304/86 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 346 - Private law |
| dewey-raw | 346.7304/86 |
| dewey-search | 346.7304/86 |
| dewey-sort | 3346.7304 286 |
| dewey-tens | 340 - Law |
| discipline | Rechtswissenschaft |
| edition | Second edition |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01531nam a2200397 c 4500</leader><controlfield tag="001">BV045265390</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20190114 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">181030s2018 xxu |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">018016836</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781641051187</subfield><subfield code="9">978-1-64105-118-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV045265390</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-M382</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">KF3133.D78</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">346.7304/86</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pre-ANDA litigation</subfield><subfield code="b">strategies and tactics for developing a drug product and patent portfolio</subfield><subfield code="c">Kenneth L. Dorsney, editor-in-chief</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">Second edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Chicago</subfield><subfield code="b">American Bar Association</subfield><subfield code="c">[2018]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xxvii, 1007 Seiten</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben und Index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="z">United States</subfield><subfield code="x">Patents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Patent laws and legislation</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug approval</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacy</subfield><subfield code="x">Law and legislation</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biotechnology</subfield><subfield code="z">United States</subfield><subfield code="x">Patents</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dorsney, Kenneth L.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe, EPUB</subfield><subfield code="z">978-1-64105-119-4</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">LoC Fremddatenuebernahme</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030653247&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030653247</subfield></datafield></record></collection> |
| id | DE-604.BV045265390 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:13:18Z |
| institution | BVB |
| isbn | 9781641051187 |
| language | English |
| lccn | 018016836 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030653247 |
| open_access_boolean | |
| owner | DE-M382 |
| owner_facet | DE-M382 |
| physical | xxvii, 1007 Seiten |
| publishDate | 2018 |
| publishDateSearch | 2018 |
| publishDateSort | 2018 |
| publisher | American Bar Association |
| record_format | marc |
| spelling | Pre-ANDA litigation strategies and tactics for developing a drug product and patent portfolio Kenneth L. Dorsney, editor-in-chief Second edition Chicago American Bar Association [2018] xxvii, 1007 Seiten txt rdacontent n rdamedia nc rdacarrier Literaturangaben und Index Drugs United States Patents Patent laws and legislation United States Drug approval United States Pharmacy Law and legislation United States Biotechnology United States Patents Dorsney, Kenneth L. edt Erscheint auch als Online-Ausgabe, EPUB 978-1-64105-119-4 LoC Fremddatenuebernahme application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030653247&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Pre-ANDA litigation strategies and tactics for developing a drug product and patent portfolio Drugs United States Patents Patent laws and legislation United States Drug approval United States Pharmacy Law and legislation United States Biotechnology United States Patents |
| title | Pre-ANDA litigation strategies and tactics for developing a drug product and patent portfolio |
| title_auth | Pre-ANDA litigation strategies and tactics for developing a drug product and patent portfolio |
| title_exact_search | Pre-ANDA litigation strategies and tactics for developing a drug product and patent portfolio |
| title_full | Pre-ANDA litigation strategies and tactics for developing a drug product and patent portfolio Kenneth L. Dorsney, editor-in-chief |
| title_fullStr | Pre-ANDA litigation strategies and tactics for developing a drug product and patent portfolio Kenneth L. Dorsney, editor-in-chief |
| title_full_unstemmed | Pre-ANDA litigation strategies and tactics for developing a drug product and patent portfolio Kenneth L. Dorsney, editor-in-chief |
| title_short | Pre-ANDA litigation |
| title_sort | pre anda litigation strategies and tactics for developing a drug product and patent portfolio |
| title_sub | strategies and tactics for developing a drug product and patent portfolio |
| topic | Drugs United States Patents Patent laws and legislation United States Drug approval United States Pharmacy Law and legislation United States Biotechnology United States Patents |
| topic_facet | Drugs United States Patents Patent laws and legislation United States Drug approval United States Pharmacy Law and legislation United States Biotechnology United States Patents |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030653247&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT dorsneykennethl preandalitigationstrategiesandtacticsfordevelopingadrugproductandpatentportfolio |